5
092
C. Chiappe et al. / Tetrahedron Letters 47 (2006) 5089–5093
and CPO at room temperature in IL/citrate buffer
Table 2. Oxidation of phenyl methylsulfide 10 with H
2 2
O
b
Run
% (v/v) of co-solvent in citrate
buffer
pH
CPO U
Conv. (%)
11:12
(R)-11 ee (%)
a
1
2
3
4
5
6
7
8
9
0
0
5.0
5.0
3.84
3.84
67.4
0
67.4
0
67.4
67.4
67.4
0
67.4
67.4
67.4
67.4
0
35
8
89:11
67:33
90:10
86:14
95:5
90:10
98:2
70:30
98:2
70:30
100:0
90:10
79:21
90:10
86:14
97
0
>99
0
>99
>99
95
30
30
50
70
30
30
50
70
30
30
30
50
70
[N1112OH][Citr]
[N1112OH][Citr]
[N1112OH][Citr]
[N1112OH][Citr]
38
11
48
17
37
8
76
19
42
25
11
24
10
[mmim][Me
[mmim][Me
[mmim][Me
[mmim][Me
2
PO
2
PO
2
PO
2
PO
4
4
4
4
]
]
]
]
4.93
4.93
0
>99
>99
>99
50
0
38
10
11
12
13
14
15
[N1112OH][OAc]
6.08
4.80
[N1112OH][OAc]/[HOAc]
[N1112OH][OAc]/[HOAc]
[N1112OH][OAc]/[HOAc]
[N1112OH][OAc]/[HOAc]
67.4
67.4
38
a
Citrate buffer 0.1 M, pH 5.0.
b
Determined by GC on a chiral 30 m Chiradex G-TA (ASTEC) column (helium flow 50 kPa, with evaporator and detector set at 200 °C, column
temperature 90 °C per 1 min, 8 °C/min, 170 °C).
[
mmim][MeSO ] in citrate buffer).9a Although more
2. Dembitsky, M. V. Tetrahedron 2003, 59, 4701–4720.
4
3
4
5
. Van Deurzen, M. P. J.; Seelbach, K.; Van Rantwijk, F.;
Kragl, U.; Sheldon, R. A. Biotransform. 1997, 15, 1–16.
. Loughlin, W. A.; Hawkes, D. B. Bioresour. Technol. 2000,
factors are responsible for the activity of enzymes in
ILs, probably in this case the pH of the medium is an
important factor able to affect enzyme activity. Racemic
sulfoxide 11, arising exclusively from the chemical
oxidation, was formed in the presence of ILs able to
shift the pH of the medium at values higher than 6.0
7
1, 167–172.
. Han, Y. J.; Watson, J. T.; Stucky, G. D.; Butler, A. J.
Mol. Catal. B 2002, 17, 1–8; Van de Velde, F.; Bakker, M.;
Van Rantwijk, F.; Rai, G.; Hager, L. P.; Sheldon, R. A.
J. Mol. Catal. B 2001, 11, 765; Aoun, S.; Baboulene, M. A.
J. Mol. Catal. B 1998, 4, 101.
or lower than 2.7 ([N1
112OH
][H PO ]/[H PO ], [Mor ]-
2 4 3 4 11
[
MeSO ] and [mmim][MeSO ]). Even for this oxidation
4 4
process, therefore, the best ILs to use as co-solvents
are [mmim][Me PO ], cholinium citrate and cholinium
acetate.
6. Petri, A.; Gambicorti, T.; Salvadori, P. J. Mol. Catal. B
2004, 27, 103–105.
2
4
7
8
9
. Trevisan, V.; Signoretto, M.; Colonna, S.; Pironti, V.;
Strukul, G. Angew. Chem., Int. Ed. 2004, 43, 4097–4099.
. Spreti, N.; Germani, R.; Incani, A.; Savelli, G. Biotechnol.
Prog. 2004, 20, 96–101.
. (a) Sanfilippo, C.; D’Antona, N.; Nicolosi, G. Biotechnol.
Lett. 2004, 26, 1815–1819; (b) Okrasa, K.; Guib e´ -Jampel,
E.; Therisod, M. Tetrahedron: Asymmetry 2003, 14, 2487–
In conclusion, results reported here are clearly evident
about the potential to use ILs as co-solvents for CPO
catalyzed reactions. As compared to the behavior
observed in conventional organic solvents, CPO in ILs
presents enhanced activity, stability and selectivity.
Moreover, the presence of IL increases substrate solubil-
ity in the reaction medium. However, to take full advan-
tage of these perceived benefits, it is necessary to choose
the ionic liquid accurately. The ability of the IL anion to
modify the medium pH is probably the first parameter
to consider in the selection of the IL to use in CPO cat-
alyzed reactions.
2
490; (c) Machado, M. F.; Saraiva, J. M. Biotechnol. Lett.
2005, 27, 1233–1239.
10. Earle, M. J.; Seddon, K. R. Pure Appl. Chem. 2000, 20,
1391; Welton, T. Chem. Rev. 1999, 99, 2071–2083;
Wasserscheid, P.; Keim, W. Angew. Chem., Int. Ed.
2
2
000, 93, 3773–3789; Sheldon, R. A. Chem. Commun.
001, 2399–2407; Olivier-Bourbigou, H.; Magna, L. J.
Mol. Catal. A 2002, 182, 419–437; Dupont, J.; de Souza,
R. F.; Suarez, P. A. Z. Chem. Rev. 2002, 102, 3667–3692;
Ionic Liquids in Synthesis; Wasserscheid, P., Welton, T.,
Eds.; Wiley-VCH, 2003; Wilkes, J. S. J. Mol. Chem. A
Acknowledgements
2
004, 214, 11–17.
1. Chiappe, C.; Pieraccini, D. J. Phys. Org. Chem. 2005, 18,
75–298.
2. Kragl, U.; Eckstein, M.; Kraftzik, N. Chem. Biotechnol.
002, 13, 565–571; van Rantwijk, F.; Lau, R. M.; Sheldon,
1
1
This was supported by Grants from MIUR and Univer-
sity of Pisa.
2
2
R. A. Trends Biotechnol. 2003, 21, 131–138; Park, S.;
Kazlauskas, R. J. Curr. Opin. Biotechnol. 2003, 14, 432–
References and notes
4
37.
1
. Morris, D. R.; Hager, L. P. J. Biol. Chem. 1996, 241,
13. Synthesis of cholinium-based ionic liquids: a choline
hydroxide methanol solution was added dropwise to an
equimolar (for neutral ILs) or a two fold excess (for the
acidic ILs) solution of the organic or inorganic acid. The
mixture was stirred under cooling for 12 h, then methanol
1
763–1768; Zaks, A.; Dodds, D. R. J. Am. Chem. Soc.
1995, 117, 10419–10424; Van Deurzen, M. P. J.; Van
Rantwijk, F.; Sheldon, R. A. Tetrahedron 1997, 53, 13183–
3220; Colonna, S.; Gaggero, N.; Rochelmi, C.; Pasta, P.
1
TIBTECH 1999, 17, 163–168; Van Rantwijk, F.; Sheldon,
R. A. Curr. Opin. Biotechnol. 2000, 11, 554–564.
was evaporated under reduced pressure. Cholinium citrate
1
[N1112OH][Citr]: H NMR (MeOH-d ) d (ppm): 3.79
6